A medication list is a handoff document. Every time a patient’s care passes from one clinician to the next — a covering physician, a new nurse, a rooming MA who started last month — the list is what the next person inherits. When the workforce is stable, the gaps in that document get filled by memory and relationship. When it isn’t, the list is all that’s left. And the US workforce is not stable.
Here is how the staffing shortage turns medication continuity into a handoff problem — and why a list the patient has confirmed is the one durable input.
The shortage is structural, not temporary
- The AAMC projects a shortage of up to 86,000 physicians by 2036, including 20,200–40,400 primary care physicians (AAMC 2024). HRSA separately projects a shortage of roughly 187,000 physicians by 2037 (J Gen Intern Med 2025).
- The national RN turnover rate was about 16–18% in recent years, and the NCSBN reported that over 138,000 nurses exited the workforce since 2022, with nearly 40% intending to leave by 2029 (NSI / NCSBN data, 2025).
- Roughly 20% of the clinical physician workforce is 65 or older, and another 22% is between 55 and 64 — a retirement wave arriving on top of the shortage (AAMC 2024).
The practical consequence for medication management is more hands touching each patient, and fewer of them staying long enough to know the patient.
Turnover breaks continuity, and continuity is where medication knowledge lives
When staff rotate, the informal knowledge that used to backstop the record leaves with them.
- High turnover and heavy reliance on temporary or rotating staff increase handoff errors, because rotating staff have less familiarity with patient history (Floodgate Medical, 2026).
- Turnover means an organization is continually losing institutional knowledge, making it harder to sustain continuity in care-management programs (CWS Health, 2026).
- Clinical handoffs are recognized as one of the highest-risk moments for significant error, which is why structured handoff frameworks exist at all (Handoff frameworks systematic review, 2025).
In a stable practice, when the list says a patient is on a drug they stopped, someone often remembers otherwise. In a high-turnover practice, nobody remembers — so the next clinician inherits the error as fact.
Multiple hands, more discrepancies — and omission is the default failure
The medication-discrepancy literature shows exactly what happens when care is fragmented across prescribers and transitions.
- Discrepancies are more likely with more medications and more changes in medications, and care transitions carry a high risk of inadvertent discontinuation in both ICU and non-ICU settings (MedRec across transitions, PMC10665121).
- Omission is consistently the most common discrepancy type — 39% in one multi-transition review, 71% in a longitudinal cohort — precisely the failure a rushed handoff produces (JAPhA 2024; Bonaudo et al., PLOS One 2018).
- Unintentional discrepancies at care transitions are driven by communication breakdown and incomplete or inaccurate documentation of the medication history (Unintentional discrepancies & ED visits, PMC11654400).
A mixed-methods study of 15 primary care clinics captured the mechanism plainly: nurses relayed medication findings to providers inconsistently — by voice, a note on the door, or a nursing note, depending on the clinic — and a dose changed by phone often never entered the record at all (Gionfriddo et al., PLOS One 2021). Every one of those informal channels depends on the same people being there tomorrow. Turnover severs them.
The one input that doesn’t turn over: the patient
Every institutional memory in the system is subject to staffing churn — except one. The patient is present at every visit, sees every prescriber, and is the only party who knows what they’re actually taking, including the OTCs, the supplements, and the medication they quietly stopped.
That’s what makes a patient-attested list valuable in a high-turnover environment specifically. It converts the medication history from tribal knowledge — held in the head of a nurse who may leave — into a durable, timestamped, patient-verified record that the next clinician can start from regardless of who onboarded last week.
- It survives the handoff. A list the patient confirmed, with attribution and a timestamp, doesn’t depend on the departing clinician’s recall.
- It carries provenance the next clinician can trust. Instead of inheriting an unverified list, the covering clinician sees what the patient themselves confirmed and what they flagged — and can weigh it accordingly.
- Patients are willing and able partners. When a pre-visit tool asked patients to raise concerns, physician reviewers verified a majority as genuine safety opportunities, and 98% of patients reported unchanged or improved relationships with their clinician afterward (Bell et al., BMJ Qual Saf 2017).
You can’t staff your way out of a discontinuity problem overnight. But you can make the medication list independent of who’s on shift — by anchoring it to the one person who is always in the room.
An honest limit
A patient-attested list doesn’t replace clinical judgment or fix staffing. The patient flags; the clinician decides. And the controlled evidence is clear that no single reconciliation tactic is a silver bullet — the first ambulatory RCT found combined interventions were required to move the needle at all (Wolff et al., J Am Board Fam Med 2014). The claim here is narrower and defensible: when continuity is broken by turnover, a patient-verified list is the input least affected by who left.
ConfirmMyMeds is a working application. It asks the patient to confirm their clinic’s medication list before the appointment, outside the portal, and returns what they confirmed and flagged — timestamped and attributed to the person who answered — so the next clinician starts from a known point rather than rebuilding it. It never writes to your record; the clinician decides what goes in the chart. We have no outcome data and make no continuity or safety claims. We’re looking for clinics to tell us where it fails.